1.0(top 50%)
impact factor
1.1K(top 20%)
papers
10.6K(top 20%)
citations
49(top 10%)
h-index
1.1(top 50%)
extended IF
1.1K
all documents
11.4K
doc citations
72(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving ConceptsInfectious Disorders - Drug Targets2011202
2Discovery and Development of VX-950, a Novel, Covalent, and Reversible Inhibitor of Hepatitis C Virus NS3.4A Serine ProteaseInfectious Disorders - Drug Targets2006194
3Plasmodium Dihydroorotate Dehydrogenase: A Promising Target for Novel Anti-Malarial ChemotherapyInfectious Disorders - Drug Targets2010176
4Overview of the Diagnosis of Cytomegalovirus InfectionInfectious Disorders - Drug Targets2011174
5Potential Roles of Histones in Host Defense as Antimicrobial AgentsInfectious Disorders - Drug Targets2008154
6A Review on Free Radicals and AntioxidantsInfectious Disorders - Drug Targets2020132
7Mycobacterium tuberculosis DNA Gyrase as a Target for Drug DiscoveryInfectious Disorders - Drug Targets2007127
8HAART in HIV/AIDS Treatments: Future TrendsInfectious Disorders - Drug Targets2018120
9Phospho-MurNAc-Pentapeptide Translocase (MraY) as a Target for Antibacterial Agents and Antibacterial ProteinsInfectious Disorders - Drug Targets2006119
10The Implication of Platelet Activating Factor in Cancer Growth and Metastasis: Potent Beneficial Role of PAF-Inhibitors and AntioxidantsInfectious Disorders - Drug Targets2009116
11The Role of Antimicrobial Peptides in Human Skin and in Skin Infectious DiseasesInfectious Disorders - Drug Targets2008103
12Drug Targets in Mycobacterial Sulfur MetabolismInfectious Disorders - Drug Targets2007101
13Respiratory Syncytial Virus Infection in Adult PopulationsInfectious Disorders - Drug Targets2012101
14Oxidative Stress and Mitochondrial Dysfunction in Sepsis: A Potential Therapy with Mitochondria-Targeted AntioxidantsInfectious Disorders - Drug Targets2009100
15Targeting the Formation of the Cell Wall Core of M. tuberculosisInfectious Disorders - Drug Targets200797
16Antiretroviral Therapy Does Not Block the Secretion of the Human Immunodeficiency Virus Tat ProteinInfectious Disorders - Drug Targets201296
17Toll-Like Receptors in Skin Infections and Inflammatory DiseasesInfectious Disorders - Drug Targets200896
18Giardiasis in the Post Genomic Era: Treatment, Drug Resistance and Novel Therapeutic PerspectivesInfectious Disorders - Drug Targets201094
19The Evolution of Extensively Drug Resistant Tuberculosis (XDR-TB): History, Status and Issues for Global ControlInfectious Disorders - Drug Targets200791
20Nucleoside Analog Inhibitors of Hepatitis C Virus ReplicationInfectious Disorders - Drug Targets200690
21The Seattle Structural Genomics Center for Infectious Disease (SSGCID)Infectious Disorders - Drug Targets200988
22Microaspiration in Intubated Critically Ill Patients: Diagnosis and PreventionInfectious Disorders - Drug Targets201184
23Virus Vasculopathy and Stroke: An Under-Recognized Cause and Treatment TargetInfectious Disorders - Drug Targets201083
24Estrogen Regulation of Adipose Tissue Functions: Involvement of Estrogen Receptor IsoformsInfectious Disorders - Drug Targets200881
25The Burgeoning Burden of Respiratory Syncytial Virus Among ChildrenInfectious Disorders - Drug Targets201280
26Drug Targets in Cytomegalovirus InfectionInfectious Disorders - Drug Targets200976
27Pilot Randomised Controlled Trial to Test Effectiveness of Facemasks in Preventing Influenza-like Illness Transmission among Australian Hajj Pilgrims in 2011Infectious Disorders - Drug Targets201473
28Evolutionary and Functional Relationships of B Cells from Fish and Mammals: Insights into their Novel Roles in Phagocytosis and Presentation of Particulate AntigenInfectious Disorders - Drug Targets201272
29Considerations on the Mechanism of Action of Artemisinin Antimalarials: Part 1 - The 'Carbon Radical' and 'Heme' HypothesesInfectious Disorders - Drug Targets201472
30Mitochondrial Dysfunction and Antioxidant Therapy in SepsisInfectious Disorders - Drug Targets201271
31Candidiasis: A Fungal Infection- Current Challenges and Progress in Prevention and TreatmentInfectious Disorders - Drug Targets201570
32Giardiasis: The Ever-Present Threat of a Neglected DiseaseInfectious Disorders - Drug Targets201068
33Tetraspanins - Gateways for InfectionInfectious Disorders - Drug Targets201268
34Exploring DNA Topoisomerases as Targets of Novel Therapeutic Agents in the Treatment of Infectious DiseasesInfectious Disorders - Drug Targets200765
35Targeting Bacterial Secretion Systems: Benefits of Disarmament in the MicrocosmInfectious Disorders - Drug Targets200765
36Malaria Heat Shock Proteins: Drug Targets that Chaperone other Drug TargetsInfectious Disorders - Drug Targets201064
37Relevance of Nutritional Antioxidants in Metabolic Syndrome, Ageing and Cancer: Potential for Therapeutic TargetingInfectious Disorders - Drug Targets200963
38Antiviral Treatment of Cytomegalovirus InfectionInfectious Disorders - Drug Targets201163
39Approaches to Minimize Infection Risk in Blood Banking and Transfusion PracticeInfectious Disorders - Drug Targets201162
40Herpes Simplex Encephalitis: From Virus to TherapyInfectious Disorders - Drug Targets201160
41Efflux Pumps in Drug Resistance of CandidaInfectious Disorders - Drug Targets200659
42The Influenza Virus NS1 Protein: Inhibitor of Innate and Adaptive ImmunityInfectious Disorders - Drug Targets200759
43Strategic Paradigm Shifts in the Antimicrobial Drug Discovery Process of the 21st CenturyInfectious Disorders - Drug Targets200757
44Novel Approaches to Antimalarial Drug DiscoveryInfectious Disorders - Drug Targets200656
45Subject Index to Volume 5Infectious Disorders - Drug Targets200655
46Antiviral Treatment of Chikungunya Virus InfectionInfectious Disorders - Drug Targets200955
47Inflammation Theories in Psychotic Disorders: A Critical ReviewInfectious Disorders - Drug Targets201354
48Influenza Virus Transmission: Basic Science and Implications for the Use of Antiviral Drugs During a PandemicInfectious Disorders - Drug Targets200752
49Bacterial Multidrug Efflux Pumps of the Major Facilitator Superfamily as Targets for ModulationInfectious Disorders - Drug Targets201651
50Role of Inhibitory BCR Co-Receptors in ImmunityInfectious Disorders - Drug Targets201250